Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 5,010.00
-140.00 (-2.72%)
At close: Jun 19, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 66.55 billion as of June 18, 2026. Its market cap has decreased by -35.77% in one year.
Market Cap
66.55B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
59.14
Stock Price
5,010.00
Market Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 66.55B, an increase of 519.07%. That is a compound annual growth rate of 8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 66.55B | -19.58% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samik Pharmaceutical Company LTD. | 84.16B |
| Sam-A Pharm. | 81.36B |
| Pharos iBio | 81.04B |
| Daehan Nupharm | 79.58B |
| Organoidsciences | 71.72B |
| GL Pharm Tech | 69.72B |
| Sinsin Pharmaceutical | 68.42B |
| Hwail Pharmaceutical | 67.26B |